Foundation for Rare Diseases x LallianSe


Do you speak LallianSe ? #28 Eve Le Bail, LallianSe

SurgeCare x LallianSe = Sparring Partner

#equitystory #sparringpartner #privateequity #financement#investment

Do you speak LallianSe ? #27 Karine Lignel, Oncodesign Precision Medicine

Voisin Consulting x Neighborhood

Very pleased to announce therenewal of our partnership withVoisin Consulting Life Sciences (VCLS) !

At LallianSe, each support is tailor-made,flexible and agile to meet the key development challenges of our clients and partners, here with NBGH

Initiative launched by Voisin Consulting Life Sciences (VCLS) and led by Sébastien Giraudier, PhD, #Neighborhood is an annual #support program for 12 #health #startups which offers a series of interviews, support, exchanges and mentoring sessions.

#NBGH asked #LallianSe to pilot the « 360° Sessions » at the instigation of Emmanuelle Deponge, involved in the selection of projects while being #LallianSe Expert for several years.

These sessions challenge all areas of business development: from planning to execution, from regulatory strategy to organization, thanks to LallianSe’s unique track record and Emmanuelle’s #expertise.

Do you speak LallianSe ? #26 Nicolas Castoldi, AP-HP

Sorbonne médecine DU GBM x LallianSe Education

March 2024

February 2024

Alongside Pierre Mozer and Alain Sezeur, LallianSe as part of the #LallianSeEducation, contributes to the management and organization of the University Diploma Valorization of Biomedical Research by Sorbonne University.

One of the first encouraged developments was to transform the traditional “lunch meeting” between students and speakers, allowing them to create a professional network. We opted for a dynamic #cocktail format, and we had the chance to witness a real live #emulsion !

The DU GBM #community is growing and will continue to develop to bring out the #talents of tomorrow within innovative #health industries.

A big thank you to Cuisine mode d’emploi for delighting us

#DUGBM #partnership #Education #formation

January 2024

Our #hospital #immersion within the #GHU Sorbonne University has allowed us to create, for 7 years already, #synergies to build the environment favorable to the success of #health innovations. Since 2023, as part of the #LallianSeEducation initiatives, the new class of the #Sorbonne University Diploma has returned to school during this training in the Valorization of Biomedical Research.

This diploma, supervised by Julie Rachline alongside Pierre Mozer and Alain Sezeur, is aimed at all researchers, engineers, administrators, health professionals, doctoral students… and others!

The training addresses all the issues of biomedical research and innovation as well as the issues of valorization beyond being a first step in initiating and developing your network.

Find the program: https://lnkd.in/dWqNVyf

Questions about the training program? Contact us at du.gbm@lallianse.com now!

November 2023

In the deployment of its hospital immersion initiatives and LallianSeEducation, the University Diploma of Sorbonne, DU GBM, whose management is ensured by Julie Rachline and whose organization is partly operated by LallianSe, we are proud to announce a new synergy made by LallianSe: a cross partnership between the DU GBM of Sorbonne Université, and the Bioentrepreneurs Launchpad program launched by the Imagine InstituteX-HEC Entrepreneurs & Université Paris Cité, Université Paris-Saclay & ESCP Business School.With very complementary approaches, one for acculturation to valorization and the other for the creation of startups, we decided to combine these training courses in order to offer 2 tailor-made courses. Contact us at du.gbm@lallianse.com now!

March 2023

Under the leadership of Pierre Mozer and Alain Sezeur as part of the #Sorbonne University Diploma: training in the Valorization of Biomedical Research co-directed by Julie Rachline, we had the opportunity to organize a #tableronde dedicated to # #health issues.

Participants Alexandru A., Empiric Capital ▪️Catherine Boule Karista ▪️ Nicolas Castoldi @Hôtel-Dieu AP-HP, Assistance Publique – Hôpitaux de Paris ▪️ Franck LE MEUR TechToMed ▪️ Jeanne TIEU-BENICHOU Future4Care not only shared their visions of e- health, but also debated and discussed the organizational, transformational and more generally consequences of our health and care system, driven by e-health.

The future is promising, the significant #opportunities and the many challenges to develop new economic models, build infrastructure, deploy solutions that meet the needs expressed by caregivers and patients alike, but also from everyone. healthcare innovation industry. Impossible to escape this fundamental #transformation: join the movement, and don’t hesitate to participate next year in #DUGBM !

Alain Sezeur Pierre Mozer Julie Rachline

January 2023

In September 2022 we announced the #lancement de LallianSe Education. In the deployment of this new initiative, and our hospital #immersion within the #GHU Sorbonne University allowing us to create #synergies for 6 years already to develop the environment favorable to the success of innovations in #health, we are proud to announce the first module of the #Sorbonne University Diploma: training in the Valorization of Biomedical Research

 
This #training, led by Julie Rachline alongside Pierre Mozer and Alain Sezeur, is aimed at all researchers, engineers, administrators, health professionals, doctoral students… and others!

Anxious to know the social, economic and regulatory environment to value and develop #innovation through a research-industry partnership, to create an innovative company, as well as to researchers in training wishing to pursue a career in the health industries.

The training addresses all the #issues of research and biomedical innovation as well as the techniques of enhancement beyond being a first stone to initiate and develop your #network.

Find the program: https://lnkd.in/dWqNVyf

The diploma training addresses all the #issues of research and biomedical innovation as well as the techniques of enhancement beyond being a first stone to initiate and develop your #network. The other two weeks of modules are scheduled for next March!

Do you speak LallianSe ? #25 Carole Nevès, BiotechStudio

First integrated into the LallianSe #community through our #events, Carole Neves joined our #community of #Experts in residence as Sparring and Operating partner, particularly with EVerZom and international clients.

Our common ambition to support the creation and development of start-ups, combined with Carole‘s keen #expertise in rare diseases, gene therapies and other innovative products, allows us to offer a 360° vision of the challenges of business development and health products

Ultimately, it is a #synergy that supports the startup’s value creation and actively contributes to its success.

Meet Carole Neves in our #𝐃𝐨𝐘𝐨𝐮𝐒𝐩𝐞𝐚𝐤𝐋𝐚𝐥𝐥𝐢𝐚𝐧𝐒𝐞?

 #health #DYSL #team #Expert #XIR

BPIFrance Le Hub x Fab’entech x LallianSe

For almost 4 years now, the relationship driven by Bpifrance Le Hub betweenFab’entech and LallianSe – Life Sciences Integrator has been enriched and developed.

Initiated as #SparringPartner following the arrival of Sébastien IVA as Chairman of the Management Board in 2020, the translation of the vision, the outline of the roadmap and the articulation of the investment thesis have gradually strengthened the agenda of interactions and existing support.

A real pleasure to support the evolution of #Fabentech towards its position as European leader!

Discover all of our feedback here 👉 link to the interview

Success story : Biomunex Pharmaceuticals

January 2024

A few months ago, in one of the last DYSL Pierre-Emmanuel Gerard, presented the key issues of BIOMUNEX PHARMACEUTICALS.

Very happy to share today this excellente news for the development of #Biomunex.

For more than 5 years, with one of our key Expert-in-Residence, Stéphane MILOT, with Loïc MOULARD also for a few months, at the helm of the outsourced Financial Department, as well as our support around different strategic and operational perspectives, #LallianSe is pleased to contribute to the success of Biomunex.

Congratulations to the entire team for starting this clinical study ! 👏

Find out more👉 https://lnkd.in/eH47-xeJ

#Partnership #innovation #biotech #healthcare #immunotherapy #XIR